Clinical Trial Update: A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating autologous stem cell therapy for liver insufficiency; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: Imperial College London | Conditions: Liver Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-10-31